 |
16 Diseases |  |
0 Trials |
|
0 Trials |  |
2 News |  |
- | autologous mesenchymal stem cells / Tianjin Medical University General Hospital
Trial completion, Phase classification: Autologous Mesenchymal Stem Cells for the Treatment of Neuromyelitis Optica Spectrum Disorders (clinicaltrials.gov) - Oct 17, 2018
P2a, N=15, Completed, Sponsor: Tianjin Medical University General Hospital
Recruiting --> Completed | Phase classification: P2 --> P2a
- autologous mesenchymal stem cells / Tianjin Medical University General Hospital
New P2 trial: Autologous Mesenchymal Stem Cells for the Treatment of Neuromyelitis Optica Spectrum Disorders (clinicaltrials.gov) - Sep 28, 2014
P2, N=15, Recruiting, Sponsor: Tianjin Medical University General Hospital